|
Market Closed -
Euronext Paris
09:25:00 19/08/2026 pm IST
|
After hours 12:14:57 am | |||
| 0.7650 EUR | +0.66% |
|
0.7650 | 0.00% |
| 17/08 | Valerio Therapeutics Nears Final Deal for Etherna Immunotherapies Purchase | MT |
| 16/07 | Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 44Cr | - | - | - | - | - |
| 1,09300Cr | |||||
| 65TCr | - | - | - | ||
| 46TCr | |||||
| 35TCr | |||||
| 29TCr |
- Stock Market
- Stocks
- ALVIO Stock
- Charts Valerio Therapeutics
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
